AGER and neoplasm: Impairment of the HMGB1-RAGE signaling axis by OVesRAGE, an oHSV designed to secrete endogenous secretory RAGE (esRAGE), inhibits MEK-Erk signaling and endothelial cell activation, resulting in enhanced anti-tumor efficacy.